Learning
We are currently refining and developing our internal training course curriculum for the remainder of 2021 into 2022. We can also reflect upon the courses
Menu
We are currently refining and developing our internal training course curriculum for the remainder of 2021 into 2022. We can also reflect upon the courses
Pharmetheus is proud to have held a PK-Sim/MoBi workshop at the FDA. As members of the Open System Pharmacology Suite management team and of the
We are happy to welcome Maddlie Bardol to our growing team. Maddlie’s research experience includes population PK/PD modelling of analgesics and sedatives and dose optimization in children. Maddlie will take on
Our systems developer Quentin Leirens had performed the simulations and post-processing within this project with colleagues from Exprimo and Janssen, check out how this helped
Most welcome to our new colleague, Miha Purg, who joins us as System administrator, based in Uppsala. Miha’s experience includes administering HPC clusters, development of scientific software, and
How can confidence in generating realistic virtual subjects for clinical trial simulation be maintained when uncertainty about multivariate normal distribution assumptions exists? Pharmetheus consultants Giovanni Smania and
We are proud to have Mats Magnusson of Pharmetheus as co-author to the publication ‘Exposure-Efficacy Analyses of Nintedanib in Patients with Chronic Fibrosing Interstitial Lung
Daniel Röshammar, Martin Bergstrand and Moustafa Ibrahim, of Pharmetheus are co-authors to the publication ‘Pharmacokinetic Modeling and Simulation Support for Age‐ and Weight‐Adjusted Dosing of Dabigatran Etexilate in
We’re extending a warm welcome to Johanna, who joined our growing PBPK team as an Associate Consultant. Johanna’s research experience includes PBPK modelling of pulmonary
Sven is Pharmetheus’ new Support Manager. He is an experienced Helpdesk manager with a background in IT Support and Infrastructure Processes. We’re honoured to have
Pharmetheus offers consulting services focused on the application of quantitative approaches to support drug development decisions..